Mood disorders are among the most prevalent forms of mental illness. Serious depression is especially common; based on a face-to-face survey conducted from December 2001 to December 2002, the past-year prevalence rate of clinically significant major depressive disorder (MDD) was estimated to be 6.6%, affecting at least 13.1 to 14.2 million Americans.1 Although many patients with recurrent episodes of illness have good symptom remission between episodes, with few residual symptoms, approximately a quarter of patients with major depression have chronic residual depressive symptoms of varying severity with only incomplete remission for many years.2 There is evidence that chronic depression is more familial, more refractory to treatment, and more impairing than episodic major depression.
Current nosologies of depressive illnesses do not, however, do a very good job of categorizing chronic depression. In DSM-IV, there are 2 major categories for depressive illness: MDD, for which there are a number of subcategories and qualifiers; and dysthymic disorder, conceptualized as a more chronic but less severe depressive illness (Table). (DSM-IV also lists minor depressive disorder and recurrent brief depressive disorder among the "criteria sets . . . for further study.")
DSM-IV relies heavily on lists of symptoms to define the categories. For MDD, 5 symptoms are required to make a diagnosis of a major depressive episode: low mood; anhedonia; changes in appetite, weight, sleep, or psychomotor activity; feelings of guilt or worthlessness; cognitive problems (such as poor concentration); and recurrent thoughts of death or suicide. For dysthymic disorder, depressed mood, along with a similar list of symptoms is specified: changes in appetite, weight, or sleep; low energy; low self-esteem; cognitive problems; and hopelessness. Minor depressive disorder requires fewer of the same symptoms as MDD.
When DSM-IV addresses the course of illness, the situation becomes much more confusing and complicated. For MDD, symptoms must be present continuously for 2 weeks and may be characterized by a single episode or be recurrent. Either can be chronic if symptoms present continuously for 2 years. The qualifier, without full interepisode recovery, can be added as well. For dysthymic disorder, symptoms must present for 2 years (1 year in children and adolescents) with no absence of symptoms lasting more than 2 months. Also, there can be no major depressive episode during the first 2 years of the disturbance (1 year for children and adolescents).
When the validity of these distinctions is examined, it becomes apparent that this multitude of diagnoses does not reflect the clinical reality of chronic depressive illnesses. The term "double depression" was introduced by Keller and colleagues3 in 1982 to describe patients with MDD and a preexisting chronic minor depression (now called dysthymic disorder). Although this term appears commonly in the clinical literature and comes closest to reflecting the clinical reality of chronic depression, it is not a DSM diagnosis and must be captured in DSM-IV by assigning 2 diagnoses (MDD and dysthymia).
The natural history of chronic depression was well described in the work of the NIH Collaborative Study on the Psychobiology of Depression. In one report from that project, 431 patients with a major depressive episode were monitored for 12 years, assessed every 6 months, and assigned to 1 of 4 symptom levels of depressive illness: major depression, dysthymia, subsyndromal symptoms, or no symptoms.2 The authors reported that 23% of patients were never symptom-free and that 88% of patients spent some follow-up weeks at 3 or 4 different symptom levels with level changes 2 to 3 times per year. They concluded that "the traditional . . . focus on MDD level of symptoms represents only the tip of the iceberg of this common, chronic and disabling disease." These data further support the idea that rather than a collection of diagnoses, chronic depressive illness is best understood as a fluctuating condition with different levels of severity over time.
McCullough and colleagues4 compared 681 outpatients with chronic depression for a broad range of demographic, clinical, psychosocial, family history, and treatment response variables. Using DSM-IV criteria, they assigned participants to 4 categories of chronic depression:
- Those who had a chronic major depressive episode lasting longer than 2 years.
- Those who had suffered at least 2 major depressive episodes but without full interepisode recovery.
- Those who had dysthymia and a major depressive episode (double depression).
- Those who had both dysthymia and a chronicmajor depressive episode.
1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder. JAMA. 2003;289: 3095-3105.
2. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55:694-700.
3. Keller MB, Shapiro RW. "Double depression": superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry. 1982;139:438-442.
4. McCullough JP Jr, Klein DN, Borian FE, et al. Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2. J Abnorm Psychol. 2003;112:614-622.
5. Klein DN, Schwartz JE, Rose S, Leader JB. Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am J Psychiatry. 2000; 157:931-939.
6. Klein DN, Norden KA, Ferro T, et al. Thirty-month naturalistic follow-up study of early-onset dysthymic disorder: course, diagnostic stability, and prediction of outcome. J Abnorm Psychol. 1998;107:338-348.
7. Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry. 2006; 163:872-880.
8. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126:983-987.
9. Klein DN, Shankman SA, Lewinsohn PM, et al. Family study of chronic depression in a community sample of young adults. Am J Psychiatry. 2004;161:646-653.
10. Klein DN, Riso LP, Donaldson SK, et al. Family study of early-onset dysthymia. Mood and personality disorders in relatives of outpatients with dysthymia and episodic major depression and normal controls. Arch Gen Psychiatry. 1995;52:487-496.
11. Mondimore FM, Zandi PP, MacKinnon DF, et al. Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees. Am J Psychiatry. 2006;163:1554-1560.
12. Mondimore FM, Zandi PP, MacKinnon DF, et al. A comparison of the familiality of chronic depression in recurrent early-onset depression pedigrees using different definitions of chronicity. J Affect Disord. 2007;100: 171-177.
13. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905-1917.
14. Zisook S, Rush AJ, Albala A, et al. Factors that differentiate early vs later onset of major depression disorder. Psychiatry Res. 2004;129:127-140.
15. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from "unipolar" to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry. 1995;52:114-123.
16. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49:809-816.
17. Kennedy N, Abbott R, Paykel ES. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med. 2003;33:827-838. .
18. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using mea- surement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28-40.
19. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231-1242.
20. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-1252.
21. Lima MS, Moncrieff J. Drugs versus placebo for dysthymia. Cochrane Database Syst Rev. 2000;(4): CD001130.
22. Guaiana G, Barbui C, Hotopf M. Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. 2003;(2):CD004186.